Advancing Innovative Immune-Oncology Technologies

Xenetic Biosciences is a biopharmaceutical company focused on advancing proprietary technology platforms across multiple high-value cancer indications.

More About Us

Combating Disease Through Innovative Therapies

Product Pipeline



Oncology platform aimed at improving immunotherapies by targeting Neutrophil Extracellular Traps (NETs)

DNase Platform

Personalized CAR T platform targeting cancers with a patient- and tumor-specific approach.

XCART Platform

Transformative Technologies

Our proprietary and patented technologies are being utilized to create life-changing therapies.

Our Novel Technologies

Stock InformationView Detailed Stock Information

Nasdaq: XBIO Xenetic Biosciences, Inc.
Day Range
52 Week Range
Investors Presentation

Get Email Alerts

Stay informed about our latest news and updates

Sign up Today